Efficient and stable transduction of resting B lymphocytes and primary chronic lymphocyte leukemia cells using measles virus gp displaying lentiviral vectors
- 8 October 2009
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 114 (15) , 3173-3180
Abstract
Up to now, no lentiviral vector (LV) tool existed to govern efficient and stable gene delivery into quiescent B lymphocytes, which hampers its application in gene therapy and immunotherapy areas. Here, we report that LVs incorporating measles virus (MV) glycoproteins, H and F, on their surface allowed transduction of 50% of quiescent B cells, which are not permissive to VSVG-LV transduction. This high transduction level correlated with B-cell SLAM expression and was not at cost of cell-cycle entry or B-cell activation. Moreover, the naive and memory phenotypes of transduced resting B cells were maintained. Importantly, H/F-LVs represent the first tool permitting stable transduction of leukemic cancer cells, B-cell chronic lymphocytic leukemia cells, blocked in G0/G1 early phase of the cell cycle. Thus, H/F-LV transduction overcomes the limitations of current LVs by making B cell–based gene therapy and immunotherapy applications feasible. These new LVs will facilitate antibody production and the study of gene functions in these healthy and cancer immune cells.Keywords
This publication has 29 references indexed in Scilit:
- Mechanisms of killing by anti-CD20 monoclonal antibodiesMolecular Immunology, 2007
- Targeting lentiviral vectors to specific cell types in vivoProceedings of the National Academy of Sciences, 2006
- Transduction of CpG DNA-stimulated primary human B cells with bicistronic lentivectorsMolecular Therapy, 2005
- Rapid and efficient nonviral gene delivery of CD154 to primary chronic lymphocytic leukemia cellsCancer Gene Therapy, 2005
- Bystander Transfer of Functional Human CD40 Ligand from Gene-Modified Fibroblasts to B-Chronic Lymphocytic Leukemia CellsHuman Gene Therapy, 2003
- IL-7 surface-engineered lentiviral vectors promote survival and efficient gene transfer in resting primary T lymphocytesBlood, 2003
- Efficiency of Onco-Retroviral and Lentiviral Gene Transfer into Primary Mouse and Human B-Lymphocytes Is Pseudotype DependentHuman Gene Therapy, 2003
- Efficient gene transfer into human primary blood lymphocytes by surface-engineered lentiviral vectors that display a T cell–activating polypeptideBlood, 2002
- Characterization of novel safe lentiviral vectors derived from simian immunodeficiency virus (SIVmac251) that efficiently transduce mature human dendritic cellsGene Therapy, 2000
- Gene transfer of CD40-ligand induces autologous immune recognition of chronic lymphocytic leukemia B cells.Journal of Clinical Investigation, 1998